InsiderTrades

Form 4 for VMD VIEMED HEALTHCARE, INC.

Accepted 2023-01-18 00:00:00 ET · period of report 2023-01-17 · accession 0001729149-23-000015 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-01-18 2023-01-18 VMD Hoyt Casey CEO, Dir M - OptEx — +42.3K 2.16M +2% —
D 2023-01-18 2023-01-18 VMD Hoyt Casey CEO, Dir D - Sale to Iss $7.77 -14.1K 2.13M -0.7% -$109.7K
DM 2023-01-18 2023-01-17 VMD Hoyt Casey CEO, Dir A - Grant $0.00 +150.3K 30.1K New $0
DM 2023-01-18 2023-01-18 VMD Hoyt Casey CEO, Dir M - OptEx $0.00 -42.3K 56.5K -43% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2023-01-18 M A 14,114 — 2,147,560 D — — (F1) Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
2 Common Common Shares 2023-01-18 M A 28,229 — 2,161,675 D — — (F2) Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
3 Common Common Shares 2023-01-18 D D 14,114 $7.77 2,133,446 D — —
4 Derivative Restricted Stock Units 2023-01-17 A A 120,205 $0.00 120,205 D — · — to 2026-01-17 120,205 Common Shares (F2) Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. (F7) Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.
5 Derivative Phantom Share Units 2023-01-18 M D 14,114 $0.00 28,228 D — · — to 2025-01-18 14,114 Common Shares (F1) Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash. (F3) Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
6 Derivative Phantom Share Units 2023-01-17 A A 30,051 $0.00 30,051 D — · — to 2026-01-17 30,051 Common Shares (F5) Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date. (F6) Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
7 Derivative Restricted Stock Units 2023-01-18 M D 28,229 $0.00 56,456 D — · — to 2025-01-18 28,229 Common Shares (F2) Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share. (F4) Restricted Stock Units (RSUs) granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date.